Guardant Health, Inc. (GH): Price and Financial Metrics

Guardant Health, Inc. (GH): $42.02

1.47 (-3.38%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

GH Price/Volume Stats

Current price $42.02 52-week high $50.89
Prev. close $43.49 52-week low $15.81
Day low $40.22 Volume 1,534,300
Day high $42.44 Avg. volume 2,333,246
50-day MA $44.53 Dividend yield N/A
200-day MA $32.97 Market Cap 5.19B

GH Stock Price Chart Interactive Chart >


Guardant Health, Inc. (GH) Company Bio


Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.


GH Latest News Stream


Event/Time News Detail
Loading, please wait...

GH Latest Social Stream


Loading social stream, please wait...

View Full GH Social Stream

GH Price Returns

1-mo -1.50%
3-mo 24.47%
6-mo 89.62%
1-year 131.52%
3-year -44.00%
5-year -30.53%
YTD 37.55%
2024 12.94%
2023 -0.55%
2022 -72.81%
2021 -22.39%
2020 64.93%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!